Clinical Handbook of Psychotropic Drugs, m. 1 Online-Zugang

Clinical Handbook of Psychotropic Drugs, m. 1 Online-Zugang
 Spiralbindung
Nicht lieferbar | Lieferzeit: Nicht lieferbar I

85,95 €* Spiralbindung

Alle Preise inkl. MwSt. | Versandkostenfrei
Artikel-Nr:
9780889375932
Veröffentl:
2021
Einband:
Spiralbindung
Seiten:
470
Autor:
Ric M. Procyshyn
Gewicht:
1516 g
Format:
280x225x24 mm
Sprache:
Englisch
Beschreibung:

The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.Independent, unbiased, up-to-date Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment options Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug Potential interactions and side effects summarized in comparison charts With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek Clearly written patient information sheets available for download as printable PDF files This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.New in this editionNeuroscience-based nomenclature - added to product availability tables Antidepressants chapter includes new section on GABAA receptor positive modulator (brexanolone IV injection; trade name Zulresso); also covers Qelbree (viloxazine extended-release capsules), the first new ADHD medication approved by the FDA in over a decade; as well as updates to SSRI use in pregnancy and antidepressant augmentation strategies Antipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairment Mood stabilisers chapter sections on lithium and anticonvulsants extensively revised New formulations and trade names include: Adhansia XR (methylphenidate extended-release capsules), Caplyta (lumateperone), Dayvigo (lemborexant), Perseris (risperidone extended-release subcutaneous injection), Probuphine (buprenorphine subdermal implant), Propecia (finasteride tablets), Trelstar (triptorelin slow-release injection), Qelbree (viloxazine extended-release capsules)
The classic reference to psychotropic medications for psychiatrists, psychologists, physicians, pharmacists, and nurses, packed with the latest drugs, completely revised sections, and much more.

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.